Jeeyun Lee
机构：Samsung Medical Center, Sungkyunkwan University · ORCID：0000-0002-4911-6165
发表论文 1103 篇 · 总被引 33644 次 · h-index 79
代表论文
- Tables S1-S10 from MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition (2026)
- Data from MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition (2026)
- Supplementary Methods 1 from MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition (2026)
- Figures S1-S11 from MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition (2026)
- GutCore: An Endoscopy Foundation Model for Whole-Case Gastric Cancer Analysis (2026 · medRxiv)
- Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancer (2026 · Cell Reports Medicine)